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Mutation of the survival motor neurons 1 (SMN1) gene causes motor neuron apoptosis and represents the
major cause of spinal muscular atrophy in humans. Biochemical studies have established that the SMN
protein plays an important role in spliceosomal small nuclear ribonucleoprotein (snRNP) biogenesis and that
the SMN complex can interact with the zinc finger protein ZPR1. Here we report that targeted ablation of the
Zpr1 gene in mice disrupts the subcellular localization of both SMN and spliceosomal snRNPs. Specifically,
SMN localization to Cajal bodies and gems was not observed in cells derived from Zpr1/ embryos and the
amount of cytoplasmic snRNP detected in Zpr1/ embryos was reduced compared with that in wild-type
embryos. We found that Zpr1/ mice die during early embryonic development, with reduced proliferation and
increased apoptosis. These effects of Zpr1 gene disruption were confirmed and extended in studies of cultured
motor neuron-like cells using small interfering RNA-mediated Zpr1 gene suppression; ZPR1 deficiency caused
growth cone retraction, axonal defects, and apoptosis. Together, these data indicate that ZPR1 contributes to
the regulation of SMN complexes and that it is essential for cell survival.
Spinal muscular atrophy (SMA) is an autosomal recessive
disease in humans that is characterized by degeneration of the
-motor neurons of the spinal cord anterior horn. Infants born
with SMA exhibit progressive muscle atrophy and paralysis
that leads to respiratory failure and early death. Severe forms
of SMA are caused by mutation of the survival motor neurons
1 (SMN1) gene (11, 24, 28, 51).
Two copies of the human SMN gene (SMN1 and SMN2) that
are located in an inverted repeat on chromosome 5q13 have
been identified. These two genes are very similar, but tran-
scripts from the SMN2 gene undergo alternative splicing due to
a translationally silent nucleotide difference (C 3 T, codon
280) in exon 7 (31, 36). In severe forms of SMA, the SMN1
gene is deleted and the SMN2 gene predominantly expresses a
truncated SMN protein that lacks sequences derived from exon
7. The expression of low levels of full-length SMN protein
causes motor neuron degeneration and SMA.
SMN has been implicated in the growth, development, and
survival of spinal cord motor neurons (34, 42, 44). Biochemical
analysis demonstrates that SMN plays an essential role in the
assembly and maturation of spliceosomal small nuclear ribo-
nucleoproteins (snRNPs) (35, 43, 53). After transcription, the
Sm class of snRNAs (U1, U2, U4, and U5) are exported to the
cytoplasm, where they are assembled with seven Sm proteins
(SmB/B’, SmD1 to SmD3, SmE, SmF, and SmG) to form
Sm-core. The SMN protein complex is required for the specific
assembly of Sm-core complexes on U snRNAs. This is medi-
ated by SMN interactions with the U snRNA (52) and with the
Arg/Gly-rich COOH tails of SmB, SmD1, and SmD3 (9). High-
affinity interactions with SMN require that these Sm proteins
be modified to contain symmetrical dimethyl-arginine (4, 10).
SMN plays a second role in the maturation of snRNPs fol-
lowing the assembly of snRNAs with Sm proteins. The Sm-core
undergoes hypermethylation to form the 2,2,7-trimethyl-
guanosine (TMG) 5-cap that is required for the recruitment of
import receptors necessary for the translocation of snRNPs into
the nucleus (50). Trimethylguanosine synthase 1 (TSG1), the
enzyme that is responsible for the formation of the TMG 5-cap,
interacts with SMN (37). The hypermethylated 5-cap of U
snRNA recruits snurportin 1 to the snRNP complex (21) and
snurportin 1 is able to bind both SMN (39) and importin  (21) to
facilitate nuclear import of mature snRNP complexes.
Recent studies have demonstrated that the zinc finger pro-
tein ZPR1 represents a new component of SMN complexes
(16). ZPR1 is part of a cytoplasmic snRNP complex that con-
tains SMN, Sm proteins, U snRNA, snurportin 1, and importin
 (39). The binding partner of ZPR1 in the SMN complex has
not yet been identified, but it has been established that ZPR1
does not directly bind SMN (16). ZPR1 colocalizes with SMN
in the nucleus, where both proteins accumulate in gems and
Cajal bodies. It is likely that the binding of ZPR1 to SMN
complexes is significant because SMN mutations that are as-
sociated with SMA disease disrupt the association of ZPR1
with SMN complexes (16). Furthermore, it is established that
SMA patients express low levels of ZPR1 (20).
The purpose of this study was to examine the role of ZPR1
in mouse development. The effect of ZPR1 deficiency was
investigated by disruption of the Zpr1 gene by using homolo-
gous recombination and also by Zpr1 gene silencing using
RNA interference. We report that ZPR1 deficiency caused
reduced growth and increased apoptosis. The effects of ZPR1
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deficiency were associated with defects in the subcellular lo-
calization of snRNPs.
MATERIALS AND METHODS
Mice. The murine Zpr1 gene was isolated from a 129/SvJ mouse  Fix II
genomic library (Stratagene), using the mouse Zpr1 cDNA as a probe. Sequence
analysis confirmed that the clone carried the Zpr1 gene. A targeting vector was
designed to replace exon 1 with a Neor cassette (see Fig. 1A). A thymidine kinase
cassette was included for negative selection. The targeting vector was linearized
with NotI, electroporated into TC1 embryonic stem cells (strain 129SvEv), and
subsequently selected with G418 and ganciclovir. Targeted clones (four) were
identified by Southern blot analysis, and two clones were used to create chimeric
mice by blastocyst injection. Both clones transmitted the disrupted Zpr1 gene
through the germ line. The mice were backcrossed to the C57BL/6J strain (The
Jackson Laboratory) and maintained by mating Zpr1/ mice. Genomic DNA
was isolated from the mouse tails with a genomic DNA isolation kit (Lamda
Biotech) and used for PCR and Southern blot analysis. The animals were housed
in a facility accredited by the American Association for Laboratory Animal Care,
and the animal studies were approved by the Institutional Animal Care and Use
Committee of the University of Massachusetts Medical School.
Blastocyst culture. Heterozygous (/) mice were intercrossed to generate
homozygous (/), heterozygous (/), and wild-type (/) mouse embryos.
Blastocysts on day 3.5 postcoitum (E3.5) were flushed out with Dulbecco mod-
ified Eagles medium (DMEM) (Invitrogen) supplemented with 15% fetal bovine
serum, -mercaptoethanol (100 M), glutamine (2 mM), and penicillin-strepto-
mycin. Individual blastocysts were cultured for 96 h in 96-well tissue culture
plates or on coverslips coated with 0.01% poly-L-lysine in either the presence or
the absence of 103 U of LIF (Chemicon) per ml. Embryo growth and morphology
were monitored at 24-h intervals. Embryos were washed with phosphate-buffered
saline, (PBS), and genomic DNA was extracted by incubation at 55°C for 3 h in
20 l of PCR lysis buffer (10 mM Tris-HCl [pH 9.0], 50 mM KCl, 2.5 mM MgCl2,
0.1% [vol/vol] Triton X-100) containing proteinase K (100 g/ml). Lysates were
boiled for 10 min and used for genotyping.
Genotyping. Genomic DNA isolated from embryonic stem cell clones and
mouse tails was used for determination of genotypes. Southern blot analysis was
performed using a random-primed 32P-labeled 425-bp probe prepared by PCR
using the primers 5-CTCAGACATGACCAGAGACC-3 and 5-CCGCTGTG
GGGCCAGGCCCG-3 and the mouse Zpr1 cDNA as the template. Genotyping
by PCR was performed to detect the wild-type allele (250 bp) using the primers
5-CCCTCAGCGCCGAGGATGAG-3 plus 5-GCAGGAAAAGGAGCTCA
CGA-3 and to detect the disrupted Zpr1 allele (444 bp) using the primers
5-CTGCGGCCTCTTTAAGAAGG-3 plus 5-CTTCTTGACGAGTTCTTCT
G-3.
Culture of NSC-34 cells. NSC-34 cells were maintained in DMEM supple-
mented with 10% fetal bovine serum, glutamine (2 mM), and penicillin-strepto-
mycin (6). Differentiated cells with properties resembling those of motor neurons
were obtained by culturing on coverslips in DMEM with 10% fetal bovine serum
(2 days) and then in medium comprising 1:1 DMEM plus Ham’s F12, 1% fetal
bovine serum, penicillin-streptomycin, and 1% modified Eagle’s medium nones-
sential amino acids. The medium was changed after 48 h and subsequently at
72-h intervals for 2 weeks.
Gene silencing with siRNA. Motor neurons were transfected with 100 nM
SMARTpool small interfering RNA (siRNA) (Dharmacon) designed to silence
the mouse Zpr1 gene or Scramble II (Control; 5-GCGCGCTTTGTAGGATT
CG-3). The SMARTpool of siRNA contained four double-stranded RNAs with
target sequences (ZPR1.1, 5-GATAATGCCTTGGTGATCA-3; ZPR1.2, 5-T
AGAAGGACTGCTGAAAGA-3; ZPR1.3, 5-TCCCAGAGCTTGAGTTTG
A-3; and ZPR1.4, 5-ACAGTTATCTGCAGAATGT-3). Similar results were
obtained using either the SMARTpool or the siRNA that targeted the sequences
ZPR1.1 or ZPR1.3 alone. Transfection was performed with Oligofectamine
(Invitrogen) by standard procedures. Cy3-labeled Luciferase GL2 duplex (Dhar-
macon) was used as a transfection control. Cells were harvested 72 h post-
transfection, and the level of ZPR1 expression was examined by immunoblot
analysis. Cover slips were processed for immunofluorescence analysis at 48 and
72 h post-transfection.
Immunofluorescence analysis. Embryos (E3.5) cultured for 96 h on coverslips
were incubated without and with 50 M 5-bromo-2-deoxyuridine (BrdU) for
1 h at 37°C. Embryos and motor neurons were fixed with 4% paraformaldehyde
in PBS for 15 min at room temperature and permeabilized with 0.2% (vol/vol)
Triton X-100 in PBS for 5 min at room temperature or fixed with methanol (5
min) and acetone (2 min) at20°C. Coverslips with blastocysts or motor neurons
were blocked with 3% bovine serum albumin in PBS with 0.5% Tween 20
(PBS-T) for 30 min at 25°C. Coverslips were labeled with primary antibodies:
anti-ZPR1 (clone LG1) (16), anti-Sm (clone Y12, LabVision); anti-TMG (Ab-1;
Oncogene Research Products), anti-splicing factor SC-35 (Sigma), or anti--
tubulin (clone TUJI; Covance) and detected with secondary antibodies coupled
with fluorophores (Molecular Probes). Actin was labeled with phalloidin conju-
gated with Alexa 546 (Molecular Probes). Apoptosis assays were performed by
detection of activated caspases using a caspase detection kit (Oncogene Re-
search Products) by labeling with fluorescein isothiocyanate (FITC)-VAD-fmk
for 1 h in culture at 37°C.
Double labeling (ZPR1-SMN) was carried out as described previously (16) by
sequential incubations (1 h) with anti-SMN (clone 2B1) (30), with Alexa 546-
conjugated anti-mouse immunoglobulin G (IgG) secondary antibody (Molecular
Probes), and then with Alexa 488-conjugated anti-ZPR1 (clone LG1) at 25°C.
Double labeling (ZPR1-p80 coilin) was carried out by sequential incubations (1
h) with rabbit anti-p80 coilin (no. R288) (1) and Alexa 546-conjugated anti-
rabbit IgG secondary antibody and then with Alexa 488-conjugated LG1 (anti-
ZPR1) at 25°C.
Triple labeling (ZPR1-SMN-BrdU) was carried out by sequential incubations
(1 h) with anti-SMN (clone 2B1), Cy5-conjugated anti-mouse IgG secondary
antibody (Jackson Immunoresearch), FITC-conjugated antibody to BrdU (BD
Pharmingen), and Alexa 546-conjugated antibody to ZPR1 (clone LG1) at 25°C.
Processed coverslips were mounted on slides with mounting medium
(Vectashield) containing 4,6-diamino-2-phenylindole (DAPI). Fluorescence mi-
croscopy was performed using a Ziess inverted microscope (Axiovert M200) or
a confocal laser scanning microscope (Leica TCS SP2) equipped with a 405-nm
diode laser. Fluorescence images were quantitated using software obtained from
Leica. Differential interference contrast images were obtained using the Ziess
inverted microscope.
Transmission electron microscopy. Mouse embryos (E3.5) were cultured for
96 h in 35-mm dishes (Nunc), washed with 0.5 M sodium cacodylate-HCl buffer
(pH 7.0), and fixed with 2 ml of 1.25% gluteraldehyde for 30 min at 30°C and
overnight at 4°C with 2 ml of 2.5% glutaraldehyde in cacodylate buffer. The
embryos were postfixed (1 h) in 1% (wt/vol) osmium tetraoxide in 0.1 M phos-
phate buffer (pH 7.2). The fixed embryos were then washed with buffer and
dehydrated through a graded ethanol series and transferred through a series of
100% ethanol and epoxy resin mixtures (LX 112/Araldite 502 epoxy resin)
starting with 2 parts ethanol and 1 part epoxy resin, followed by a mixture of 1
part ethanol and 2 parts epoxy resin, and finally three changes of full-strength
epoxy resin and were polymerized overnight at 70°C. The epoxy blocks were cut
and mounted on blank epoxy stubs with a drop of Super Glue, and ultrathin
sections were cut on a Reichart-Jung ultramicrotome using a diamond knife. The
sections were collected and mounted on copper support grids in serial order,
contrasted with lead citrate and uranyl acetate, and examined on a Philips CM 10
transmission electron microscope at 80-kV accelerating voltage.
Scanning electron microscopy. Mouse embryos were fixed as described for
transmission electron microscopy, dehydrated in graded alcohol (30, 50, 70, and
95% ethanol for 20 min each and then 100% ethanol twice for 20 min), and then
critical-point dried in liquid CO2. The dried embryo samples were mounted onto
aluminum stubs with silver conductive paste and sputter coated with gold-palla-
dium alloy (60:40). The specimens were examined using an ETEC autoscan
scanning electron microscope at 20-kV accelerating voltage.
RESULTS
Targeted disruption of the murine Zpr1 gene. To define the
physiological role of ZPR1, we examined the effect of disrup-
tion of the murine Zpr1 gene. A targeting vector was designed
to replace exon 1 of the Zpr1 gene with a Neor cassette (Fig.
1A). This vector was electroporated into embryonic stem cells.
Four correctly targeted cell clones were identified by Southern
blot analysis (Fig. 1B). Two clones were injected into
C57BL/6J blastocysts to obtain chimeric mice that were
crossed with C57BL/6J mice. Chimeric mice derived from both
of these clones transmitted the disrupted Zpr1 allele through
the germ line (Fig. 1C).
Comparison of wild-type and heterozygous Zpr1/ mice
did not lead to the detection of obvious morphological differ-
ences. Breeding Zpr1/ mice yielded wild-type and heterozy-
gous mice at weaning, but no homozygous Zpr1/ mice were
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found (Table 1). Similarly, genotyping of postimplantation em-
bryos did not indicate the presence of Zpr1/ embryos. We
therefore examined preimplantation embryos at the blastocyst
stage at E3.5. This analysis led to the identification of wild-
type, heterozygous, and homozygous knockout embryos (Fig.
1D) in the expected Mendelian ratios (Table 1). These data
indicate that ZPR1 deficiency caused a lethal defect in early
development.
ZPR1 deficiency causes defective embryonic growth. To de-
termine the cause of embryonic death due to loss of ZPR1, we
FIG. 1. Targeted disruption of mouse Zpr1. (A) Exon-intron structure (coding and noncoding exons are numbered and represented by solid
and open boxes, respectively) and restriction map of the mouse Zpr1 gene, structure of the targeting vector, and structure of the mutated allele
after homologous recombination. (B) The mutated Zpr1 allele was detected by Southern blot analysis and PCR. Genomic DNA from targeted
embryonic stem cells was digested with EcoRI and detected with cDNA probe (exons 10 to 14; bp 954 to 1379). The 17.5-kb fragment
corresponding to the wild-type (WT) allele and the 9.0-kb fragment corresponding to the mutated (knockout [KO]) allele are indicated.
(C) Genomic DNA samples were also examined by PCR; the wild-type (WT) allele (250 bp) and mutated (KO) allele (444 bp) are shown.
(D) Genomic DNA prepared from E3.5 embryos cultured in vitro for 96 h was genotyped by PCR.
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examined the growth and development of E3.5 blastocysts in
vitro. All embryos appeared to be similar when visualized un-
der differential interference contrast light microscopy at E3.5
(0 h; Fig. 2A). The blastocysts were cultured and observed at
24-h intervals. Both wild-type (Fig. 2A) and heterozygous
Zpr1/ (data not shown) embryos showed normal growth,
spreading of trophoblast giant cells, and growth of the inner
cell mass surrounded by trophectoderm. In contrast, Zpr1/
embryos were delayed in growth and failed to form normal
trophectoderm and expand the inner cell mass (Fig. 2A). Ad-
dition of leukemia inhibitory factor stimulated the growth of
the inner cell mass in wild-type and heterozygous Zpr1/
embryos but did not affect the proliferation of these cells in
Zpr1/ embryos (data not shown). Culture for 120 to 144 h
resulted in substantial growth of wild-type and heterozygous
embryos, but very few viable cells derived from Zpr1/ em-
bryos were detected (data not shown).
To further characterize the growth of embryos, we examined
cultured embryos by scanning electron microscopy. Wild-type
embryos contained a large inner cell mass surrounded by tro-
phectoderm formed by trophoblast giant cells (Fig. 2B, top).
Mutant embryos were significantly smaller. The inner cell mass
of the mutant embryos contained only a few cells that were
surrounded by a thin layer of irregular trophectoderm (Fig. 2B,
top). Furthermore, higher magnification of these embryos
showed marked differences in the apical surface of embryonic
cells between wild-type and mutant embryos (Fig. 2B, bottom).
The surface of the cells that form the trophectoderm and inner
cell mass of wild-type embryos contained a high density of
specialized projections (microvilli) that increase cell surface
area and are involved in transport-secretion, enzymatic activ-
ity, and signal transduction. In contrast, cells of mutant em-
bryos showed a smooth surface and were devoid of microvilli
(Fig. 2B). These data demonstrate that ZPR1 deficiency
caused defects in the apical surface of embryonic cells, includ-
ing the loss of microvilli.
ZPR1 deficiency causes increased apoptosis. To determine
the cause of the developmental defect observed in Zpr1/
embryos, we performed biochemical analysis of mouse em-
bryos cultured in vitro. The impaired growth of Zpr1/ em-
bryos (Fig. 2A and B) suggested that ZPR1 deficiency might
cause increased cell death. To test this hypothesis, we exam-
ined the activation of apoptotic caspases in cultured blastocysts
by incubation with FITC-VAD-fmk. Confocal laser-scanning
microscopy detected very little activated caspase in wild-type
embryos (Fig. 2C). In contrast, a marked increase in the
amount of activated caspase was detected in Zpr1/ embryos.
This observation suggests that ZPR1-deficient cells may exhibit
increased apoptosis. Indeed, ultrastructural analysis by trans-
mission electron microscopy demonstrated the presence of en-
gulfed apoptotic bodies within the cytoplasm of the trophoblast
giant cells of Zpr1/ embryos but not wild-type embryos (Fig.
2D). Analysis of the inner cell mass of Zpr1/ embryos dem-
onstrated the presence of cells with an early apoptotic mor-
phology (chromatin condensation and nuclear folding; Fig.
2D) and also cells undergoing late-stage apoptosis (data not
shown). In contrast, no apoptosis within the inner cell mass of
wild-type embryos was detected (Fig. 2D). Together, these
data indicate that increased apoptosis contributes to the poor
development of Zpr1/ embryos.
ZPR1 is required for proliferation. In addition to increased
apoptosis (Fig. 2), the poor development of Zpr1/ embryos
may result from reduced cell proliferation. We therefore in-
vestigated DNA synthesis in wild-type and Zpr1/ embryos by
examining the incorporation of BrdU into DNA during the S
phase of the cell cycle (Fig. 3A). Immunofluorescence analysis
demonstrated that trophoblast giant cells did not incorporate
BrdU in this assay. In contrast, marked incorporation of BrdU
by the inner cell mass of wild-type embryos was observed.
However, experiments using Zpr1/ embryos indicated that
BrdU incorporation was restricted to only a few cells in the
inner cell mass (Fig. 3A). Together, these data demonstrated
that Zpr1/ embryos exhibit a severe defect in proliferation.
It is likely that this reduced proliferation (Fig. 3A) together
with increased apoptosis (Fig. 2C and D) accounts, in part, for
the death of Zpr1/ embryos.
The absence of BrdU incorporation into the trophoblast
giant cells in this assay most probably reflects the observation
that these cells undergo several rounds of endoreduplication
during early development prior to cell cycle arrest. To examine
whether this early endoreduplication of trophoblast giant cells
might be affected by ZPR1 deficiency, we quantitated the nu-
clear DNA by measurement of DAPI fluorescence (Fig. 3A).
The nuclear DNA content of ZPR1-deficient trophoblast giant
cells was 52%  11% (mean  standard deviation SD; n	 10)
of the nuclear DNA of wild-type trophoblast giant cells (Fig.
3A). The cross-sectional area of the nucleus of ZPR1-deficient
trophoblast giant cells was also smaller than that of wild-type
cells (63%  4%; n 	 10).
Together, these data indicate that ZPR1 deficiency causes
reduced proliferation of the inner cell mass and reduced en-
doreduplication of the trophoblast giant cells.
ZPR1 deficiency causes defects in Cajal bodies. It has been
established in previous studies that nuclear ZPR1 localizes to
gems and Cajal bodies (16). Cajal bodies were observed by
transmission electron microscopy in both trophoblast giant
cells and the inner cell mass of wild-type embryos (Fig. 2D). In
contrast, electron microscopy examination of serial sections of
cells derived from Zpr1/ embryos failed to detect Cajal bod-
ies (Fig. 2D). These data suggest that ZPR1 deficiency causes
major defects in the electron-dense structure of Cajal bodies.
To test this hypothesis, we examined the subnuclear distribu-
tion of p80 coilin, a cytological marker for Cajal bodies (1). In
wild-type embryos, a small amount of coilin was diffusely dis-
tributed within the nucleoplasm and the majority of coilin was
found to accumulate in Cajal bodies (Fig. 3B). In marked
contrast, coilin was diffusely localized to the nucleoplasm in
Zpr1/ embryos (Fig. 3B). Interestingly, the total immuno-
fluorescent staining of coilin in Zpr1/ cells was markedly
increased compared to that in wild-type cells (Fig. 3B). This
TABLE 1. Progeny of heterozygous Zpr1/ mice intercrosses
Stage
No. of Zpr1 mice that were:
Total no.
/ / / Untyped
Born live 28 53 0 0 81
E13.5 8 18 0 0 26
E9.5 10 21 0 0 31
E3.5 18 28 14 9 69
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FIG. 2. Mutation in Zpr1 results in cell death and early embryonic death in mice. (A) Differential interference contrast images of wild-type
(WT) and mutant (KO) blastocysts (E3.5) at 0 h and after 96 h of culture in vitro. The inner cell mass (ICM) is surrounded by trophoblast giant
(TG) cells. Scale bar, 100 m. (B) Scanning electron micrographs of WT and mutant embryos (KO) cultured in vitro for 96 h. The ICM is growing
on the trophectoderm (TE) formed by trophoblast giant cells in WT embryos. The ICM and TE of mutant embryo (KO) display defective growth
(top; magnification, 
200; scale bar, 100 m). Microvilli (MV), projections at the apical surface of cells from wild-type embryos, are absent in
mutant (KO) embryos (bottom; magnification, 
1,000; scale bar, 10 m). (C) In situ detection of caspase activation, using FITC-VAD-fmk and
confocal laser-scanning microscopy. Activated caspase (green) in WT and mutant (KO) embryos was observed. Nuclei were stained with DAPI
(blue). The mutant embryo exhibited a large amount of caspase activation. Scale bar, 40 m. (D) Transmission electron micrographs of trophoblast
giant cells (top) and cells from the ICM (bottom). The mutant embryo (KO) shows apoptotic bodies (AB) phagocytosed by the trophoblast giant
cells, as well as aggregation of heterochromatin and accumulation at nuclear membrane (bottom). Arrowheads show nucleolar accessory bodies
(Cajal bodies). Scale bar, 1.0 m.
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FIG. 3. ZPR1 deficiency results in defective embryo growth and causes mislocalization of SMN and coilin. (A) Blastocysts (E3.5) cultured in
vitro were labeled with 50 M BrdU for 1 h at 37°C. Wild-type (WT) and mutant (KO) embryos were stained with mouse monoclonal antibodies
to ZPR1 (red), SMN (purple), and BrdU (green) and examined by indirect-immunofluorescence microscopy. Nuclei were stained with DAPI
(blue). Scale bar, 100 m. (B) Colocalization of ZPR1 and coilin in mouse embryos. Blastocysts were stained with antibodies to coilin (red) and
ZPR1 (green). Colocalization of coilin (red) and ZPR1 (green) is represented by yellow. Nuclei were stained with DAPI (blue). Scale bar, 8.0 m.
(C) Colocalization of SMN and ZPR1 in mouse embryos. Blastocysts (E3.5) cultured for 96 h were stained with antibodies to SMN (red) and ZPR1
(green) and examined by confocal laser-scanning immunofluorescence microscopy. Colocalization of SMN (red) and ZPR1 (green) is represented
by yellow. Scale bar, 8.0 m.
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increased staining may be caused by epitope unmasking when
coilin redistributes from Cajal bodies to the nucleoplasm in
Zpr1/ cells, since studies of Zpr1 gene silencing caused sim-
ilar changes in the subnuclear localization of coilin in the
absence of increased coilin expression detected by immunoblot
analysis (data not shown).
The ZPR1-associated protein SMN is also a marker for
gems and Cajal bodies (16, 30). We therefore examined the
localization of SMN in wild-type and Zpr1/ embryos. Immu-
nofluorescence analysis of wild-type embryos demonstrated
the presence of punctate intranuclear staining that colocalized
with ZPR1 (Fig. 3C). In contrast, punctate intranuclear local-
ization of SMN was not observed in Zpr1/ embryos (Fig.
3C).
Together, these data indicate that ZPR1 deficiency causes
mislocalization of proteins (e.g., coilin and SMN) that nor-
mally accumulate in Cajal bodies and gems. This conclusion is
consistent with the observation that electron microscopy de-
tected Cajal bodies in wild-type embryos but not in Zpr1/
embryos (Fig. 2D). The loss of Cajal bodies in Zpr1/ em-
bryos is likely to be biologically significant because these sub-
nuclear bodies have been implicated in multiple aspects of
RNA biogenesis (14, 40). Interestingly, it has been previously
established that the association of coilin with Cajal bodies
depends on active transcription since treatment of cells with
actinomycin D causes relocalization of coilin from Cajal bodies
to the nucleolar periphery (5, 47).
ZPR1 is required for the normal subcellular distribution of
spliceosomal snRNPs. It has been established in previous stud-
ies that SMN plays an important role in the assembly of the
Sm-core domain of snRNPs in the cytoplasm (35, 43, 53). In
addition, cytoplasmic SMN can form a preimport snRNP com-
plex with snurportin 1, importin , and ZPR1 (39). ZPR1
deficiency may therefore cause changes in the subcellular lo-
calization of snRNPs. To test this hypothesis, we examined
wild-type and Zpr1/ embryos by immunofluorescence mi-
croscopy by staining with antibodies to Sm proteins (Fig. 4A)
and to the TMG 5-cap of U snRNA (Fig. 4B). No marked
differences between the distribution of Sm proteins and the
TMG 5-cap were observed, indicating that these epitopes pri-
marily identify similar groups of snRNP complexes.
Immunofluorescence analysis demonstrated that ZPR1 de-
ficiency caused major changes in the subcellular distribution of
snRNPs (detected as Sm proteins or TMG 5-cap). In wild-
type embryos, snRNPs accumulated in the nucleus and were
reproducibly detected in the cytoplasm. The location of
snRNPs in both the nuclear and cytoplasmic compartments of
wild-type cells is consistent with the established role of nuclear
export and nuclear reimport during snRNP biogenesis (50). In
marked contrast, snRNPs were detected only at very low levels
in the cytoplasm of ZPR1-deficient embryos (Fig. 4). In addi-
tion, ZPR1 deficiency caused a marked change in the sub-
nuclear localization of snRNPs because snRNPs were partially
excluded from the nucleolus in wild-type embryos but accumu-
lated within the nucleolus of Zpr1/ embryos (Fig. 4). Inter-
estingly, the effect of ZPR1 deficiency in causing localization of
snRNPs within the nucleolus (Fig. 4) is similar to the effect of
treatment of cells with the protein phosphatase inhibitor oka-
daic acid (32, 47).
To further characterize the effect of ZPR1 deficiency on the
subcellular localization of Sm proteins and snRNPs, we per-
formed quantitative analysis of images obtained by confocal
immunofluorescence miscoscopy. The cytoplasmic and nuclear
Sm protein staining in wild-type cells was 33%  2% and 67%
 2% (n 	 10), respectively. In contrast, ZPR1-deficient cells
showed decreased cytoplasmic ZPR1 staining (2%  1%) and
increased nuclear staining (98%  1%; n 	 10). Quantitation
of the staining of snRNPs indicated cytoplasmic and nuclear
staining of 37%  3% and 63%  3% (n 	 10), respectively.
ZPR1 deficiency caused decreased staining of snRNPs in the
cytoplasm (11%  2%) and increased staining in the nucleus
(89%  2%; n 	 10). These quantitative data confirm the
conclusion that ZPR1 deficiency caused decreased cytoplasmic
accumulation and increased nuclear accumulation of both Sm
proteins and snRNPs.
Together, these data indicate that ZPR1 deficiency causes
major defects in the subcellular localization of snRNPs. This
observation suggested that ZPR1 deficiency may alter the nor-
mal function of spliceosomal snRNPs. Previous studies have
demonstrated that the SC35 splicing factor can be detected in
“nuclear speckles” and that these speckles aggregate when
pre-mRNA splicing is disrupted (41). We therefore examined
the subnuclear localization of the SC35 splicing factor. Immu-
nofluorescence analysis demonstrated aggregation of the SC35
“nuclear speckles” in ZPR1-deficient embryos (data not
shown). Together, these data indicate that ZPR1 deficiency
influences snRNP complexes, the major target of SMN activity.
RNA interference-mediated suppression of Zpr1 gene ex-
pression causes mislocalization of SMN and snRNPs. SMA is
caused by the degeneration of -motor neurons of the spinal
cord. Motor neurons therefore represent a cell type that is
relevant to SMA disease. Since Zpr1/ mice die during early
embryonic development, we were not able to study Zpr1/
motor neurons. Consequently, we used an alternative ap-
proach, Zpr1 gene silencing by siRNA, to examine the effect of
ZPR1 deficiency. These studies were performed using the
NSC-34 mouse cell line, which can be induced to differentiate
into cells that have motor neuron-like properties. Control stud-
ies demonstrated that these cells express both ZPR1 and SMN
(Fig. 5A). Immunofluorescence analysis demonstrated exten-
sive colocalization of ZPR1 and SMN in the soma and growth
cones. The amount of nuclear accumulation of SMN and
ZPR1 in these cells was small, but SMN and ZPR1 were found
to colocalize in gems and Cajal bodies (Fig. 5A and B). Zpr1
siRNA, but not scambled siRNA, caused decreased expression
of ZPR1 detected by immunoblot analysis (see Fig. S1 in the
supplemental material). Similarly, immunofluorescence analy-
sis demonstrated that Zpr1 siRNA, but not scrambled siRNA
(Control), caused decreased expression of ZPR1 (Fig. 5B).
Interestingly, both ZPR1 and SMN were detected in gems and
Cajal bodies in control cells, but this localization was not de-
tected following Zpr1 gene silencing (Fig. 5B). Similarly, coilin
was localized to Cajal bodies in differentiated NSC-34 cells but
was found to be diffusely distributed in the nucleoplasm fol-
lowing Zpr1 gene silencing (data not shown). These data con-
firm that ZPR1 is essential for the localization of SMN to gems
and Cajal bodies.
To investigate whether ZPR1 influences snRNPs in NSC-34
cells, we examined the localization of snRNPs by immunoflu-
orescence analysis using an antibody to the TMG 5-cap of U
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snRNA that is assembled into snRNP complexes (Fig. 5C).
Differentiated NSC-34 cells transfected with scrambled siRNA
(Control) demonstrated the presence of snRNP in both the
cytoplasm and the nucleus. In contrast, no cytoplasmic snRNPs
were detected in cells following Zpr1 gene silencing. Further-
more, snRNPs were excluded from the nucleolus of control
motor neurons but were present in the nucleolus of ZPR1-
depleted cells.
Together, these data demonstrate that ZPR1 deficiency
causes defects in the localization of both SMN and spliceoso-
mal snRNPs in early embryos (Fig. 3 and 4) and cultured
NSC-34 cells (Fig. 5).
ZPR1 deficiency causes axonal defects. Axonal defects in
motor neurons as a result of SMN deficiency have been de-
scribed, and it is likely that such defects contribute to the
pathogenesis of SMA (34, 44). We therefore examined
whether ZPR1 deficiency might cause axonal defects in
NSC-34 cells. Morphology was assessed by immunofluores-
cence analysis using an antibody to tubulin and phalloidin to
stain actin (Fig. 6). Neurons transfected with scrambled siRNA
(Control) demonstrated the presence of tubulin in axons and
actin in both the soma and growth cones. Zpr1 gene silencing
caused retraction of growth cones and disruption of the struc-
tural integrity of axonal microtubules. Control axons were long
and straight, whereas the axons of ZPR1-deficient neurons
were kinked and short. These data indicate that ZPR1 is im-
portant for the maintenance of motor neuron axons and
growth cones.
FIG. 4. ZPR1 deficiency causes defects in snRNP localization. (A) Loss of ZPR1 results in nuclear and nucleolar accumulation of Sm proteins.
Wild-type (WT) and mutant (KO) blastocysts (E3.5) were cultured in vitro for 96 h and stained with antibodies to Sm proteins (green). All stained
samples were examined by confocal laser-scanning immunofluorescence microscopy. Nuclei were stained with DAPI (blue). Scale bar, 20 m.
(B) Deficiency of ZPR1 causes nuclear and nucleolar accumulation of snRNPs. Embryos were stained with antibodies to TMG 5-cap of U snRNA
for detection of snRNPs (red) in wild-type and mutant embryos. Scale bar, 20 m.
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ZPR1 is essential for cell survival. The apoptotic degener-
ation of motor neurons in SMA patients causes progressive
muscle weakness. Since these patients express low levels of
ZPR1 (20), we considered the possibility that ZPR1 deficiency
might contribute to motor neuron death. To test this hypoth-
esis, we investigated the effect of Zpr1 gene silencing on
caspase activation in differentiated NSC-34 cells. Activated
caspase was detected by immunofluorescence analysis after
incubation of the motor neurons with FITC-VAD-fmk. Cells
transfected with scrambled siRNA (Control) did not exhibit
caspase activation (Fig. 7A). In contrast, caspase activation was
observed in cultures of neurons transfected with Zpr1 siRNA.
The most prominent staining of activated caspase appeared to
correspond to apoptotic bodies derived from dead cells that
were adherent to viable cells (Fig. 7A).
The observation that ZPR1 deficiency is associated with
caspase activation suggests that the loss of ZPR1 might cause
apoptosis. To test this hypothesis, we examined the effect of
transfecting cultures of NSC-34 cells with scrambled siRNA or
Zpr1 siRNA. The cells were cultured for 72 h, and the number
of surviving neurons was examined by staining nuclear DNA
with DAPI (Fig. 7B). Zpr1 gene silencing caused marked de-
creases in both the level of ZPR1 expression and the number
of surviving neurons. The decreased neuronal survival was
prevented by incubation with the caspase inhibitor zVAD-fmk
(Fig. 7B). Together, these data demonstrate that ZPR1 is crit-
ical for sustaining cell survival.
DISCUSSION
The results of this study establish that Zpr1 is an essential
gene in mice (Table 1) and that ZPR1 is required for the
maintenance of motor neurons (Fig. 6 and 7). The ZPR1
protein interacts with SMN and is a component of cytoplasmic
snRNP complexes (16,39). The observation that ZPR1 defi-
ciency causes defects in the subcellular localization of snRNPs
and SMN (Fig. 3 to 5) indicates that the interaction between
ZPR1 and SMN is biologically significant. Interestingly, SMN
mutations that are associated with the inherited disease SMA
disrupt the interaction of ZPR1 with SMN (16). Furthermore,
human patients with SMA express low levels of ZPR1 (20). In
mice, ZPR1 deficiency prevents the localization of SMN to
gems and Cajal bodies (Fig. 3 and 5); this may be significant for
SMA because it is established that the severity of SMA nega-
tively correlates with the number of SMN-positive gems and
Cajal bodies (7, 29). Together, these data indicate that ZPR1
may contribute to SMN-associated disease.
ZPR1 and SMN prevent apoptosis. SMN functions as a
component of a protein complex (17) that includes the zinc
finger protein ZPR1 (16, 39). SMN mutations that cause SMA
disrupt the interaction of SMN with several components of this
protein complex, including ZPR1 (16). The correlation be-
tween the interaction of ZPR1 with SMN and motor neuron
degeneration in SMA suggests that ZPR1 and SMN may rep-
resent components of a common functional pathway.
It is established that loss of function, or mutation, of SMN
can induce caspase-mediated apoptosis (22, 26, 45, 49). Simi-
larly, mutation or silencing of the murine Zpr1 gene causes
casapse activation and apoptosis (Fig. 2 and 7). The mecha-
nism of apoptosis caused by Smn and Zpr1 mutations may be
FIG. 5. Loss of ZPR1 causes mislocalization of SMN and snRNPs
in differentiated NSC-34 cells. (A) Colocalization of SMN with ZPR1
in differentiated NSC-34 cells that resemble motor neurons. The cells
were stained with antibodies to SMN and ZPR1 and examined by
confocal laser-scanning immunofluorescence microscopy. Colocaliza-
tion of SMN (red) with ZPR1 (green) is represented by yellow in
nuclear bodies (top, see inset; scale bar, 40 m) and in the neuronal
growth cone (bottom, see inset; scale bar, 8.0 m). (B) A low level of
ZPR1 results in the loss of nuclear bodies and mislocalization of
nuclear SMN in motor neurons. Motor neurons were transfected with
scrambled siRNA (Control) and ZPR1-specific siRNA (siRNA) and
cultured for 48 h. Cellular distribution of SMN (red) and ZPR1
(green) were examined using antibodies to SMN and ZPR1. Scale bar,
16 m. (C) Loss of ZPR1 causes nuclear accumulation of snRNPs.
Cells were transfected with scrambled siRNA (Control) and ZPR1-
specific siRNA (siRNA), were cultured for 72 h, and stained with
antibodies to ZPR1 (green) and TMG 5-cap (red). Scale bar, 8.0 m.
Nuclei were stained with DAPI (blue).
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related, since it is known that SMN is essential for splicesomal
snRNP assembly and maturation (35, 43, 53) and that ZPR1
deficiency causes defects in the subcellular localization of both
SMN and snRNPs (Fig. 4 and 5). Interestingly, these effects of
ZPR1 deficiency on the subcellular distribution of snRNPs and
apoptosis resemble the effects of decreased expression of the
SMN-interacting protein Gemin2 (23). Together, these data
indicate that both ZPR1 and the SMN protein complex can
function to sustain cell survival.
Nucleocytoplasmic trafficking and function of ZPR1. ZPR1
redistributes between the cytoplasm and the nucleus (12, 13,
15). Genetic analysis indicates that the nuclear export of ZPR1
requires the peptidylprolyl isomerase activity of cyclophilin A
(2), while biochemical studies suggest that snurportin 1 may
contribute to the nuclear import of ZPR1 (39). This nucleo-
cytoplasmic trafficking of ZPR1 resembles the trafficking of
SMN (16), although it should be noted that the nuclear import
of ZPR1 and SMN appear to be mediated by independent
mechanisms (38) and it is unclear whether the mechanisms of
ZPR1 and SMN export from the nucleus are related. Never-
theless, SMN and ZPR1 are both detected in the cytoplasm
and the nucleus. The cytoplasmic function of ZPR1 may be to
collaborate with SMN in the assembly and maturation of
snRNPs to form preimport complexes with snurportin 1 (39).
FIG. 6. Deficiency of ZPR1 causes defects in axons of differentiated NSC-34 cells. (A) Loss of ZPR1 causes axonal defects in differentiated
NSC-34 cells that resemble motor neurons. Cells transfected with scrambled siRNA (Control) and ZPR1-specific siRNA (siRNA) were cultured
for 72 h and stained with antibodies to tubulin (red) and ZPR1 (green). The arrowhead indicates the kinks in the axon of motor neuron after
knockdown of ZPR1 (siRNA). Scale bar, 20 m. (B) ZPR1 deficiency results in the loss of growth cones of differentiated NSC-34 cells. ZPR1 was
stained with antibodies to ZPR1 (green), and actin was stained with phalloidin conjugated with Alexa 546 (red). Nuclei were stained with DAPI
(blue). All samples were examined by confocal laser-scanning fluorescence microscopy. Scale bar, 20 m.
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The effect of ZPR1 deficiency to disrupt the cytoplasmic lo-
calization of snRNP complexes is consistent with this hypoth-
esis (Fig. 4 and 5).
In the nucleus, SMN and ZPR1 are found in the nucleo-
plasm, but these proteins also accumulate in gems and Cajal
bodies (16, 30). These subnuclear bodies have been implicated
in several aspects of RNA biogenesis (14, 33, 40). For example,
recent studies have established that the guide RNA molecules
that are required for site-specific modification of snRNAs are
localized to Cajal bodies (27) and it has been demonstrated
that the synthesis of 2-O-methylated nucleotides and
pseudouridine in snRNAs occurs following nuclear import of
snRNPs within Cajal bodies (25). Interestingly, Cajal bodies
were not detected in Zpr1/ embryos (Fig. 2D and 3B). Thus,
ZPR1 may play an essential role in the maintenance of nuclear
gems and Cajal bodies. Since these subnuclear bodies are dy-
namic structures that can exchange their protein components
with the nucleoplasm (8), there are several possible mecha-
nisms that could account for the requirement of ZPR1 to
maintain these structures. Nevertheless, it appears that in ad-
dition to a cytoplasmic function that may contribute to the
assembly of snRNPs and formation of preimport snRNP com-
FIG. 7. Loss of ZPR1 results in death of differentiated NSC-34 cells. (A) Low levels of ZPR1 causes caspase activation and death of
differentiated NSC-34 cells that resemble motor neurons. Cells transfected with scrambled siRNA (Control) and ZPR1-specific siRNA (siRNA)
were cultured for 72 h and labeled with FITC-VAD-fmk. Motor neurons stained with antibodies to ZPR1 (red) and activated caspase (green) were
examined by confocal laser-scanning microscopy. Scale bar, 20 m. (B) Inhibition of death of motor neurons that lack ZPR1 by zVAD. Cells were
left untreated (zVAD) or treated (zVAD) with zVAD (10 M) during transfection with scrambled siRNA (Control) and ZPR1-specific siRNA
(siRNA). Samples were stained with antibodies to ZPR1 and examined by confocal laser-scanning microscopy. Nuclei were stained with DAPI
(blue). Scale bar, 40 m.
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plexes (39), ZPR1 may contribute to the final maturation of
imported snRNP complexes within Cajal bodies.
Previous studies have established coilin as a cytological
marker for Cajal bodies (1). The coilin NH2-terminal region is
able to self-associate (18), and the COOH terminus is able to
recruit SMN by binding to symmetrical dimethylarginine resi-
dues located within an Arg-Gly-rich domain (3, 19). A major
difference between cells that display gems and those that do
not is that the COOH-terminal region of coilin is hypomethy-
lated in cells containing gems and Cajal bodies and is fully
methylated in cells containing only Cajal bodies (19). Interest-
ingly, the COOH-terminal region of coilin can regulate the
number of Cajal bodies (46), and deletion of this region pre-
vents the recruitment of both SMN and snRNP complexes to
Cajal bodies (48). In Zpr1/ embryos, Cajal bodies were not
detected by electron microscopy (Fig. 2D) and the nuclear
distribution of coilin was profoundly altered (Fig. 3B). Consis-
tent with the established role of coilin to recruit SMN, no
accumulation of SMN in Cajal bodies was observed in Zpr1/
embryos. It is possible that ZPR1 deficiency results in the
formation of residual gems or Cajal bodies that lack coilin and
SMN. Nevertheless, these data demonstrate that ZPR1 is es-
sential for the normal morphology of gems and Cajal bodies.
Conclusions. Our studies of Zpr1 gene silencing and Zpr1
gene disruption demonstrate that ZPR1 is an essential protein.
ZPR1 deficiency causes defects in both the cytoplasmic and
nuclear populations of spliceosomal snRNPs. Specifically, cy-
toplasmic snRNPs are not detected in Zpr1/ embryos. Fur-
thermore, ZPR1 deficiency markedly disrupts the subnuclear
structures (gems and Cajal bodies) where final maturation of
snRNP complexes is observed. These data are consistent with
a collaborative role of ZPR1 in the function of SMN to medi-
ate snRNP assembly/maturation and cell survival. The low
level of ZPR1 expression in patients with spinal muscular at-
rophy may therefore contribute to disease progression.
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